Neyra Javier A, Manllo John, Li Xilong, Jacobsen Gordon, Yee Jerry, Yessayan Lenar
Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Tex., USA.
Nephron Clin Pract. 2014;128(3-4):373-80. doi: 10.1159/000368902. Epub 2015 Jan 13.
Acute kidney injury (AKI) occurs frequently in septic patients. Albuminuria may play a role as an early marker of septic AKI. The potential association between de novo dipstick albuminuria (DA) and septic AKI has not been examined.
We conducted a single-center observational cohort study of 423 critically ill septic patients without chronic kidney disease (CKD) or prior positive DA within 3 months before admission. The association between de novo DA within the first 24 h of presentation and AKI at 72 h was examined.
AKI was identified in 268/423 (63%) patients and 20/423 (4.7%) required dialysis. De novo DA was associated with AKI (univariate OR 1.91; 95% CI 1.27-2.86, p = 0.002). The association persisted in a multivariate logistic regression model adjusted for demographics, baseline kidney function, comorbidities, critical illness parameters, and exposure to nephrotoxins (adjusted OR 1.87; 95% CI 1.21-2.89, p = 0.005). The association between de novo DA and AKI was stronger for severe AKI, i.e. Acute Kidney Injury Network (AKIN) stage 3 (adjusted OR 2.99; 95% CI 1.52-5.85, p = 0.001) and AKIN stage 2 (adjusted OR 1.79; 95% CI 1.002-3.21, p = 0.049) but not AKIN stage 1 (adjusted OR 1.41; 95% CI 0.87-2.29, p = 0.16).
De novo DA within the first 24 h of admission was independently associated with severe AKI in critically ill septic patients. Future studies are required to fully elucidate the utility of DA testing in the early detection and stratification of AKI.
急性肾损伤(AKI)在脓毒症患者中频繁发生。蛋白尿可能作为脓毒症性AKI的早期标志物发挥作用。新发试纸法蛋白尿(DA)与脓毒症性AKI之间的潜在关联尚未得到研究。
我们对423例无慢性肾脏病(CKD)或入院前3个月内无既往阳性DA的危重症脓毒症患者进行了一项单中心观察性队列研究。研究了就诊后24小时内新发DA与72小时时AKI之间的关联。
268/423(63%)例患者被诊断为AKI,20/423(4.7%)例患者需要透析。新发DA与AKI相关(单因素OR 1.91;95%CI 1.27 - 2.86,p = 0.002)。在对人口统计学、基线肾功能、合并症、危重症参数和接触肾毒素进行校正的多因素逻辑回归模型中,该关联仍然存在(校正OR 1.87;95%CI 1.21 - 2.89,p = 0.005)。新发DA与AKI之间的关联在严重AKI中更强,即急性肾损伤网络(AKIN)3期(校正OR 2.99;95%CI 1.52 - 5.85,p = 0.001)和AKIN 2期(校正OR 1.79;95%CI 1.002 - 3.21,p = 0.049),但在AKIN 1期不明显(校正OR 1.41;95%CI 0.87 - 2.29,p = 0.16)。
入院后24小时内新发DA与危重症脓毒症患者的严重AKI独立相关。未来需要进行研究以充分阐明DA检测在AKI早期检测和分层中的效用。